Wells Fargo & Company Fulgent Genetics, Inc. Transaction History

Wells Fargo & Company

$407 Billion
Q2 2024

A detailed history of Wells Fargo & Company transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 10,891 shares of FLGT stock, worth $229,473. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,891

Previous 10,293 5.81%

Holding current value

$229,473

Previous $223,000 4.48%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$19.09 - $22.57 $11,415 - $13,496	598 Added 5.81%	10,891 $213,000
Q1 2024 May 10, 2024	BUY	$21.55 - $29.29 $6,508 - $8,845	302 Added 3.02%	10,293 $223,000
Q4 2023 Feb 09, 2024	BUY	$23.64 - $30.27 $26,713 - $34,205	1,130 Added 12.75%	9,991 $288,000
Q3 2023 Nov 13, 2023	SELL	$26.74 - $40.81 $116,880 - $178,380	-4,371 Reduced 33.03%	8,861 $236,000
Q2 2023 Aug 15, 2023	BUY	$28.52 - $40.7 $111,056 - $158,485	3,894 Added 41.7%	13,232 $489,000
Q1 2023 May 12, 2023	BUY	$29.39 - $36.27 $96,487 - $119,074	3,283 Added 54.22%	9,338 $291,000
Q4 2022 Feb 13, 2023	SELL	$29.23 - $40.28 $10,084 - $13,896	-345 Reduced 5.39%	6,055 $180,000
Q3 2022 Nov 14, 2022	SELL	$37.92 - $63.74 $282,769 - $475,309	-7,457 Reduced 53.81%	6,400 $244,000
Q2 2022 Aug 12, 2022	SELL	$47.98 - $62.75 $947,365 - $1.24 Million	-19,745 Reduced 58.76%	13,857 $755,000
Q1 2022 May 16, 2022	SELL	$49.85 - $96.11 $1.43 Million - $2.76 Million	-28,722 Reduced 46.08%	33,602 $2.1 Million
Q4 2021 Feb 14, 2022	BUY	$77.3 - $105.0 $732,958 - $995,610	9,482 Added 17.94%	62,324 $6.27 Million
Q3 2021 Nov 15, 2021	SELL	$74.87 - $110.87 $392,393 - $581,069	-5,241 Reduced 9.02%	52,842 $4.75 Million
Q2 2021 Aug 16, 2021	SELL	$66.8 - $100.45 $380,158 - $571,660	-5,691 Reduced 8.92%	58,083 $5.36 Million
Q1 2021 May 13, 2021	BUY	$59.3 - $183.85 $383,374 - $1.19 Million	6,465 Added 11.28%	63,774 $6.16 Million
Q4 2020 Feb 09, 2021	BUY	$31.01 - $52.1 $163,639 - $274,931	5,277 Added 10.14%	57,309 $2.99 Million
Q3 2020 Nov 05, 2020	BUY	$15.89 - $50.51 $447,780 - $1.42 Million	28,180 Added 118.15%	52,032 $2.08 Million
Q2 2020 Aug 13, 2020	BUY	$8.89 - $18.28 $128,931 - $265,114	14,503 Added 155.13%	23,852 $382,000
Q1 2020 May 14, 2020	BUY	$6.75 - $19.75 $63,105 - $184,642	9,349 New	9,349 $100,000

Others Institutions Holding FLGT

# of Institutions

195

Shares Held

15.3M

Call Options Held

1.07M

Put Options Held

27.9K

View Full List

About Fulgent Genetics, Inc.

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $638M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

More about FLGT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Fulgent Genetics, Inc. Transaction History